Clinical trials
Enrolling by invitation Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Wellcome Sanger Institute | 3 |
| AstraZeneca | 1 |
| Janssen Research & Development, LLC | 1 |
| Manchester University NHS Foundation Trust | 1 |
| Novo Nordisk A/S | 1 |
| USWM CT, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 8 |
| Congenital Abnormalities | 1 |
| Developmental Disabilities | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dwarfism, Pituitary | 1 |
| Genetic Predisposition to Disease | 1 |
| Head and Neck Neoplasms | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.